A Look Inside the Toolbox for BRAF-Mutant Metastatic Melanoma

Season 3 Episode 1  ·  Feb 15, 2022, 04:00 PM
Headliner
Share
Subscribe

In season 3, episode 1 of Targeted Talks, Michael A. Postow, MD, discusses available targeted agents for BRAF-mutant melanoma and ongoing clinical questions about treating the disease.

Share
Subscribe
Next
Advances and Pending Innovations in the Treatment of Sarcoma
Top episodes
Individualizing Immunotherapy in Non–Small Cell Lung Cancer
by Targeted Talks
The Importance of Trastuzumab Deruxtecan in HER2+ Breast Cancer Treatment
by Targeted Talks
Modern Strategies Improving Immunotherapy in Cancer
by Targeted Talks